Pull 4 Parkinson’s Foundation, Inc., a registered 501(c)(3) public charity,
funds cure and care research conducted by the Parkinson's disease community.
Learn More or Donate.

2282 Parkinson’s Trials Are Being Tracked

Trial Name Last Updated
CREAD Study: A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD) 03/20/2018
Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease 03/20/2018
A Study of Pimavanserin for the Treatment of Agitation and Aggression in Subjects With Alzheimer's Disease 03/20/2018
Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003 03/20/2018
A Phase 2 RCT Study of CX-8998 for Essential Tremor 03/20/2018
Multiple Ascending Dose Study of Intravenously Administered BMS-986168 in Patients With Progressive Supranuclear Palsy 03/20/2018
Dysport® Adult Upper Limb Spasticity Extension Study 03/20/2018
Dysport® Adult Upper Limb Spasticity 03/20/2018
A Study of LY3002813 and LY3202626 in Participants With Early Symptomatic Alzheimer's Disease 03/20/2018
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort 03/20/2018
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo 03/20/2018
Tilt-Table Study of the Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension 03/20/2018
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E) 03/20/2018
Effect of PBT2 in Patients With Early to Mid Stage Huntington Disease 03/20/2018
A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer's Disease 03/20/2018
Phase IV-Cervical Dystonia-INTEREST IN CD2 03/20/2018
Gaucherite - A Study to Stratify Gaucher Disease 03/20/2018
Open-label Extension Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia 03/20/2018
Coenzyme Q10 in Huntington's Disease (HD) 03/20/2018
A Study of Pridopidine (ACR16) for the Treatment of Patients With Huntington's Disease 03/20/2018
The Purpose of This Study is to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of ABBV-8E12 in Subjects With Progressive Supranuclear Palsy (PSP). 03/20/2018
Study of a Single Administration of 3 Doses of Dysport® for the Treatment of Benign Essential Blepharospasm 03/20/2018

Page 2 of 104 pages  < 1 2 3 4 >  Last ›

All ClinicalTrials.gov articles provided courtesy of National Library of Medicine (NLM).